Market cap
$18 Mln
Recently Viewed
Clear AllMarket cap
$18 Mln
Revenue (TTM)
$57 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-15 Mln
ROE
-0.8 %
ROCE
-- %
Industry P/E
53.55
EV/EBITDA
0.2
Debt to Equity
0.6
Book Value
$--
EPS
$-5.7
Face value
--
Shares outstanding
7,877,490
CFO
$-338.49 Mln
EBITDA
$-379.96 Mln
Net Profit
$-411.05 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ConforMIS Inc (CFMS)
| -31.9 | 0.0 | 105.5 | -66.1 | -50.1 | -39.8 | -- |
|
BSE Sensex*
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
ConforMIS Inc (CFMS)
| -82.5 | 15.3 | -56.0 | 319.0 | -84.8 | -70.6 | -53.2 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as... provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts. Read more
CEO, Pres & Director
Mr. Mark A. Augusti
CEO, Pres & Director
Mr. Mark A. Augusti
Headquarters
Billerica, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of ConforMIS Inc (CFMS) is $2.26 (NASDAQ) as of 14-Sep-2023 09:30 EDT. ConforMIS Inc (CFMS) has given a return of -50.09% in the last 3 years.
Since, TTM earnings of ConforMIS Inc (CFMS) is negative, P/E ratio is not available.
The P/B ratio of ConforMIS Inc (CFMS) is 0.37 times as on 14-Sep-2023, a 89 discount to its peers’ median range of 3.27 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.48
|
0.44
|
|
2021
|
-2.26
|
0.05
|
|
2020
|
-0.09
|
0.19
|
|
2019
|
-0.14
|
0.24
|
|
2018
|
-0.02
|
0.02
|
The 52-week high and low of ConforMIS Inc (CFMS) are Rs -- and Rs -- as of 25-Apr-2026.
ConforMIS Inc (CFMS) has a market capitalisation of $ 18 Mln as on 14-Sep-2023. As per SEBI classification, it is a Small Cap company.
Before investing in ConforMIS Inc (CFMS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.